Alcon Inc. vs Harvard Bioscience, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Alcon Inc. is the larger company by market value: $37.1 B against $38 M for Harvard Bioscience, Inc., 986 times as much (market caps of Aug 1, 2026 for Alcon Inc. and Oct 26, 2026 for Harvard Bioscience, Inc.). Alcon Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Alcon Inc. had more revenue: $10.4 B against $87 M for Harvard Bioscience, Inc., both in the year to December 2025.
- Alcon Inc. made a net profit of $980 M, while Harvard Bioscience, Inc. made a net loss of $57 M.
- Alcon Inc. keeps more of each dollar of sales: a net margin of 9.4% against -65.5% for Harvard Bioscience, Inc.
- Alcon Inc.'s revenue grew faster in its latest fiscal year: +4.9% against -8.1% for Harvard Bioscience, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Alcon Inc. ALC · #705 in the world | Harvard Bioscience, Inc. HBIO · #22,291 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇭 Switzerland | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments | Medical Instruments |
| Founded | 1945 | 1901 |
| Size | ||
| Market cap | $37.1 B | $38 M |
| Revenue | $10.4 B | $87 M |
| Net income | $980 M▲ best | $-57 M |
| Employees | 25,000 | — |
| Valuation | ||
| P/E ratio | 37.9× | — |
| Price to sales | 3.6× | 0.4× |
| Price to book | 1.7× | 2.7× |
| Free cash flow yield | 4.7% | 14.5%▲ best |
| Profitability | ||
| Gross margin | 55.2% | 57.7%▲ best |
| Operating margin | 13.1%▲ best | -56.1% |
| Net margin | 9.4%▲ best | -65.5% |
| Return on equity | 4.5%▲ best | -147.1% |
| Growth | ||
| Revenue growth | 4.9%▲ best | -8.1% |
| Revenue growth, 3 years a year | 6.1%▲ best | -8.6% |
| Earnings per share growth | -3.4% | — |
| Financial strength | ||
| Debt to equity | 0.2×▲ best | 2.6× |
| Interest cover | — | -37.4× |
| Cash | ||
| Free cash flow margin | 16.6%▲ best | 6.3% |
| Strength scores | ||
| Piotroski F-score | — | 5 of 9 |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Alcon Inc. or Harvard Bioscience, Inc.?
Alcon Inc. is the larger company by market value: $37.1 B against $38 M for Harvard Bioscience, Inc., 986 times as much (market caps of Aug 1, 2026 for Alcon Inc. and Oct 26, 2026 for Harvard Bioscience, Inc.). Alcon Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Alcon Inc. or Harvard Bioscience, Inc.?
Alcon Inc. had more revenue: $10.4 B against $87 M for Harvard Bioscience, Inc., both in the year to December 2025. Alcon Inc. made a net profit of $980 M, while Harvard Bioscience, Inc. made a net loss of $57 M.
Which is more profitable, Alcon Inc. or Harvard Bioscience, Inc.?
Alcon Inc. keeps more of each dollar of sales: a net margin of 9.4% against -65.5% for Harvard Bioscience, Inc.
Which is growing faster, Alcon Inc. or Harvard Bioscience, Inc.?
Alcon Inc.'s revenue grew faster in its latest fiscal year: +4.9% against -8.1% for Harvard Bioscience, Inc.
More about Alcon Inc.
More about Harvard Bioscience, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.